Cover Image
市場調查報告書

心臟再同步化治療用心律調節器 (CRT-P)的全球市場:2016∼2020年

Global Cardiac Resynchronization Therapy Pacemaker Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 363484
出版日期 內容資訊 英文 48 Pages
訂單完成後即時交付
價格
Back to Top
心臟再同步化治療用心律調節器 (CRT-P)的全球市場:2016∼2020年 Global Cardiac Resynchronization Therapy Pacemaker Market 2016-2020
出版日期: 2016年07月15日 內容資訊: 英文 48 Pages
簡介

心臟再同步化治療用心律調節器 (CRT-P) 是最新型的心律調節器之一,觀察血流和心室的運動,同時進行收縮以調整心臟節律。與一般心律調節器不同,CRT-P有導線,與2個右心室和左心室雙方相連。全球CRT-P市場,預計2016∼2020年以8.17%的年複合成長率成長。

本報告提供全球心臟再同步化治療用心律調節器 (CRT-P) 市場相關分析,市場概要和結構,市場規模趨勢 (今後5年的預測值),各用途、各地區的詳細趨勢,推動、阻礙市場要素與其影響力,主要企業簡介,今後的市場機會等調查評估。

第1章 摘要整理

  • 分析結果的概要

第2章 分析範圍

  • 分析概要
  • 大供應商的主要產品

第3章 市場分析技術

  • 分析方法
  • 經濟指標

第4章 簡介

  • 市場趨勢的概要

第5章 心臟再同步化治療用心律調節器 (CRT-P)的市場環境

  • 市場概要
  • 市場規模與其預測
  • 波特的五力分析

第6章 CRT-P與植入手術的成本分析

第7章 地區區分

  • 南北美洲的CRT-P市場
  • 歐洲、中東、非洲各國 (EMEA)的CRT-P市場
  • 亞太地區的CRT-P市場

第8章 主要國家市場

  • 美國
  • 法國
  • 英國
  • 德國

第9章 心臟再同步化治療用心律調節器 (CRT-P)的全球市場:推動因素

  • 心血管疾病的發病率
  • 由政府輔助的啟發計劃
  • 低侵入性治療的引進
  • 亞太地區的CRT-P需求

第10章 推動因素的影響力

第11章 心臟再同步化治療用心律調節器 (CRT-P)的全球市場:課題

  • 替代性手段的登場
  • 精通的人力資源不足
  • 潛在的併發症風險
  • 兒童患者方面的CRT-P限制

第12章 推動因素、課題的影響力

第13章 心臟再同步化治療用心律調節器 (CRT-P)的全球市場:趨勢

  • 對研究開發 (R&D) 及臨床實驗的關注
  • 機器人支援型心血管手術受歡迎
  • 對無導線CRT-P的關注

第14章 供應商環境

  • 競爭方案

第15章 主要供應商分析

  • BIOTRONIK
  • Boston Scientific
  • LivaNova
  • Medtronic
  • St. Jude Medical

第16章 附錄

  • 簡稱集

第17章 關於Technavio

目錄
Product Code: IRTNTR8951

About Cardiac Resynchronization Therapy-pacemaker (CRT-P)

CRT-Ps are an advanced implantable form of conventional pacemakers. They help the heart function efficiently by monitoring its signals and coordinating with the ventricles to contract at the same time. These devices resynchronize the heart's rhythm to improve breathlessness and fatigue, and avoid dizziness and fainting in individuals.

Physicians surgically implant the CRT-P under the skin, below the collarbone. They connect the electrical leads through a blood vessel into the heart. Unlike conventional pacemakers, CRT-Ps have two leads: one placed into the right ventricle and the other in the right atrium. An extra lead is implanted on the left side of the heart to stimulate the left ventricle, assisting the heart to pump efficiently.

Technavio's analysts forecast the global cardiac resynchronization therapy-pacemaker (CRT-P) market to grow at a CAGR of 8.17% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global cardiac resynchronization therapy-pacemaker (CRT-P) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of CRT-Ps.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • BIOTRONIK
  • Boston Scientific
  • LivaNova
  • Medtronic
  • St. Jude Medical

Market driver

  • Implementation of minimally invasive procedures
  • For a full, detailed list, view our report

Market challenge

  • Risk of potential complications
  • For a full, detailed list, view our report

Market trend

  • Popularity of robot-assisted cardiac surgery
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Cost analysis of CRT-Ps and implantation

PART 07: Geographical segmentation

  • CRT-P market in Americas
  • CRT-P market in EMEA
  • CRT-P market in APAC

PART 08: Key leading countries

  • US
  • France
  • UK
  • Germany

PART 09: Market drivers

  • Incidence of cardiovascular diseases
  • Government-aided awareness programs
  • Implementation of minimally invasive procedures
  • Demand for CRT-Ps in APAC

PART 10: Impact of drivers

PART 11: Market challenges

  • Presence of alternatives
  • Lack of skilled personnel
  • Risk of potential complications
  • Limitations of CRT-Ps in pediatric patients

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Focus on R&D and clinical trials
  • Popularity of robot-assisted cardiac surgery
  • Focus on leadless CRT-Ps

PART 14: Vendor landscape

  • Competitive scenario

PART 15: Key vendor analysis

  • BIOTRONIK
  • Boston Scientific
  • LivaNova
  • Medtronic
  • St. Jude Medical

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global CRT-P market 2015-2020 ($ millions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Cost comparison of CRT-P and ICD and their implantation
  • Exhibit 05: Global CRT-P market segmentation by geography 2015
  • Exhibit 06: Global CRT-P market segmentation by geography 2020
  • Exhibit 07: Global CRT-P market segmentation by geography 2015-2020
  • Exhibit 08: CRT-P market in Americas 2015-2020 ($ millions)
  • Exhibit 09: CRT-P market in EMEA 2015-2020 ($ millions)
  • Exhibit 10: CRT-P market in APAC 2015-2020 ($ millions)
  • Exhibit 11: CRT-P market in US 2015-2020 ($ millions)
  • Exhibit 12: CRT-P market in France 2015-2020 ($ millions)
  • Exhibit 13: CRT-P market in UK 2015-2020 ($ millions)
  • Exhibit 14: CRT-P market in Germany 2015-2020 ($ millions)
  • Exhibit 15: Impact of drivers
  • Exhibit 16: Impact of drivers and challenges
  • Exhibit 17: BIOTRONIK: Product portfolio
  • Exhibit 18: BIOTRONIK: Key takeaways
  • Exhibit 19: Boston Scientific: Cardiac rhythm management segmentation by revenue 2015
  • Exhibit 20: Boston Scientific: Cardiac rhythm management segmentation by revenue 2014 and 2015 ($ millions)
  • Exhibit 21: Boston Scientific: Geographical segmentation of cardiac rhythm management by revenue 2015
  • Exhibit 22: Key takeaways: Boston Scientific
  • Exhibit 23: LivaNova: Product portfolio
  • Exhibit 24: LivaNova: Key takeaways
  • Exhibit 25: Medtronic: Product portfolio
  • Exhibit 26: Key takeaways: Medtronic
  • Exhibit 27: St. Jude Medical: Product portfolio
  • Exhibit 28: Key takeaways: St. Jude Medical
Back to Top